Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy

Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare and the Director of the Centre of Pharmaceutical Policy and Practice Research at the University of Huddersfield, United Kingdom. A pharmacist by training, Prof Babar is the recipient of the prestigious “Research Excellence Award “ from the University of Auckland. He understands the health systems and pharmacy globally and is known for his work in pharmaceutical policy and practice, including quality use of medicines, evidence and impact, access to medicines, medicine prices and issues related to pharmacoeconomics. He has published in high impact journals such as PLoS Medicine and Lancet and has acted as a consultant for World Health Organization, Royal Pharmaceutical Society, Health Action International, International Union Against Tuberculosis and Lung Disease, World Bank, International Pharmaceutical Federation (FIP) and for the Pharmaceutical Management Agency of New Zealand. His edited workincludes "Economic evaluation of pharmacy services", “Pharmaceutical prices in the 21st century”, “Pharmaceutical policies in countries with developing healthcare systems ", “Global Pharmaceutical Policy”, "Equitable access to high-cost medicines" “Pharmacy Practice Research Methods”, “Social and Administrative Aspects of Pharmacy in Low and Middle-Income Countries” and the “Encyclopedia of Pharmacy Practice and Clinical Pharmacy”. Published by Elsevier and Adis/Springer, the books are used in curriculum design, policy development and for referral all around the globe. Professor Babar is the Editor-in-Chief of the BMC Journal of Pharmaceutical Policy and Practice and can be contacted at z.babar@hud.ac.uk

• Global Changes, Development, Evidence and Impact in General.- Evident and Impact of Health Services Research and Pharmaceutical Public Health.- Evidence andIimpact of Pharmacoepidemiology and Pharmacovigilance Research.- Evidence and Impact of Research Methodologies Used in Health Services Research in Pharmacy and Pharmaceutical Public Health.- Evidence and Impact of Health Services Research in Pharmacy and Pharmaceutical Public Health in High Income Countries.- Evidence and Impact of Health Services Research in Pharmacy and Pharmaceutical Public Health in LMICs.- Evidence and Impact of Health Services Research in Pharmacy and Pharmaceutical Public Health in the UK.- Evidence and Impace of Pharmacoeconomics Research.- Evidence and Impact of Interventions, Medicines and Medical Technologies in COVID-19 and Other Pandemics.- Evidence and Impact of “Medicines Access and Use Research”.- Evidence and Impact of Research Related to Pharmacogenomics and Precision Medicine